← Daily Disruptor / July 24, 2026

Daily Disruptor: $EOSE — Zinc Storage Hits Pentagon, Grid, and $1B Project Platform at Once

Sector research: The generative ad stack →

Three catalysts converged on $EOSE in the last ten days, and the market has so far punished the stock on dilution fears rather than rewarded the operational evidence. That disconnect is the setup worth watching.

Frontier Power USA is funded and launching. Yesterday, July 23, Eos announced that its rights offering — combined with $100M from Cerberus Capital Management and $50M from Hudson Bay Capital Management — raised approximately $263 million in gross equity for Frontier Power USA, exceeding its $250M target. With roughly 75% loan-to-value project debt layered on top, that equity base is expected to support more than $1 billion in deployable project capital. The JV’s initial close is expected in early August, and its pipeline already holds roughly 16 GWh of opportunities, with ~1.8 GWh already under construction or near notice to proceed, including the 100MW/400MWh Wildfire BESS project in Caldwell County, Texas.

The Golden Dome contract is real. On July 15, Eos announced a multi-million-dollar partnership with the U.S. Department of War to deploy its Z3 zinc-based long-duration energy storage as an initial prototype at a critical defense installation under the Golden Dome for America initiative. The award was called out publicly by President Trump at Senator Dave McCormick’s Defense and National Security Summit. The Z3 carries ~91% domestic content and is Section 842 NDAA and FEOC compliant — a meaningful procurement moat. $EOSE’s Thorn Hill facility in Pittsburgh is also expanding toward a target of 8 GWh annual capacity with a goal of 1,000 regional jobs.

The numbers are moving fast. Preliminary Q2 2026 revenue of $68–69M would be the highest quarterly revenue in company history, driven by a more-than-threefold increase in shipments year-over-year. Combined with Q1’s $56.9M, first-half 2026 revenue has already surpassed full-year 2025. Backlog grew 25% sequentially to ~$807M as of June 30, and Battery Line 2 entered commercial production in mid-June. Full Q2 results drop August 5 with an 8:30 a.m. ET call — that’s your hard date to circle.

The risk is serious and must be stated plainly. Gross margin loss in Q2 is guided at 69–73%, meaning Eos is selling every dollar of battery for roughly $0.30 or less. The company burned through cash during the production ramp, stock has dropped ~40% from late-June highs, and JPMorgan cut its price target to $6 on July 21. The rights offering was significantly undersubscribed — only 6.9M of 27.4M units were purchased by shareholders. Dilution from warrants trading as $EOSEW is material, securities fraud investigations from early 2026 have not been formally resolved, and the path from a loss-making manufacturer to a profitable one requires Battery Lines 2 and beyond to drive unit economics down a steep curve. This is a high-risk, high-volatility name. Not financial advice.

Automated post — read before relying on anything above. This content was generated with AI assistance and published automatically without individual human review prior to publication. It may contain errors, outdated figures, or mischaracterizations; verify every figure against the company's SEC filings and official releases before relying on it.

Positions and business relationships. Assume that Dr. Paul Christianson and/or Disruptor Investing, LLC may hold a long or short position in any security mentioned above, whether or not a position is stated, and may buy or sell at any time without notice. Assume also that a company mentioned above may be a current or former paid client of Disruptor Investing's CEO interview program, or may otherwise have a business relationship with Disruptor Investing, whether or not that relationship is stated above. These relationships are material conflicts of interest and should be weighed against everything stated in this post.

Nothing here is investment, legal, tax, or financial advice, an offer, or a solicitation to buy or sell any security. Dr. Christianson is not a registered financial advisor, investment adviser, or broker-dealer. Educational content only. Investing involves risk of loss, including total loss of principal; micro-cap and small-cap securities carry heightened risk. Full disclosures, positions, and compensation terms.